SCHEMBL6350275

SCHEMBL6350275

N#Cc1ccc(NC(=O)c2cccc(C(=NO)c3ccccc3)c2)c(C(=O)O)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 6/20 0.53
▸ MEN1 O00255 5/20 0.53
▸ PKM P14618 2/20 0.53
▸ GFER P55789 1/20 0.52
▸ SERPINE1 P05121 3/20 0.47
▸ F2 P00734 1/20 0.47
▸ PLG P00747 1/20 0.47
▸ PLAU P00749 1/20 0.47
▸ KLKB1 P03952 1/20 0.47
▸ PRSS1 P07477 1/20 0.47
▸ ALB P02768 1/20 0.47
▸ AKR1C4 P17516 3/20 0.46
▸ AKR1C3 P42330 3/20 0.46
▸ AKR1C2 P52895 3/20 0.46
▸ AKR1C1 Q04828 3/20 0.46
▸ MAPT P10636 2/20 0.46
▸ TDP1 Q9NUW8 2/20 0.46
▸ ALDH1A1 P00352 1/20 0.46
▸ ABL1 P00519 1/20 0.46
▸ TSHR P16473 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6350272 1.00 KMT2A (0.53) KMT2AMEN1PKMGFERSERPINE1
SCHEMBL6350803 0.87 KMT2A (0.51) KMT2AMEN1PKMGFERSERPINE1
SCHEMBL6350806 0.87 KMT2A (0.51) KMT2AMEN1PKMGFERSERPINE1
SCHEMBL6359203 0.86 KMT2A (0.58) KMT2AMEN1PKMGFERSERPINE1
SCHEMBL6353963 0.85 KMT2A (0.62) KMT2AMEN1PKMGFERSERPINE1
SCHEMBL6352203 0.84 SERPINE1 (0.58) SERPINE1AKR1C4AKR1C3AKR1C2AKR1C1
SCHEMBL6352208 0.84 SERPINE1 (0.58) SERPINE1AKR1C4AKR1C3AKR1C2AKR1C1
SCHEMBL6351469 0.83 AKR1C2 (0.66) KMT2AMEN1PKMGFERSERPINE1
SCHEMBL6349736 0.82 AKR1C2 (0.69) KMT2AMEN1PKMGFERSERPINE1
SCHEMBL6349741 0.82 AKR1C2 (0.69) KMT2AMEN1PKMGFERSERPINE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050113450-A1 Antibacterial agents PHARMACIA & UPJOHN COMPANY 2005-05-26 — — US claimed
WO-2004018414-A2 ANTIBACTERIAL AGENTS PHARMACIA & UPJOHN COMPANY LLC (US) 2004-03-04 — — WO claimed
US-20050113450-A1 Antibacterial agents PHARMACIA & UPJOHN COMPANY 2005-05-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050113450-A1 Antibacterial agents CLPP, SPOUT1, SAMHD1 KMT2A 3645/4885MEN1 3274/4885PKM 4573/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback